{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["Adenocarcinoma","Adenocarcinoma of the Rectum","Colorectal cancer metastatic","Colorectal Neoplasms","Metastatic colorectal cancer","Advanced Colorectal Cancer","Colorectal cancer recurrent","Colorectal cancer stage IV","Adenocarcinoma of the Colon"],"disease":["Adenocarcinoma","Metastatic Colorectal Cancer","Colorectal Cancer Stage Iv","Adenocarcinoma Of The Rectum","Colorectal Cancer Recurrent","Colorectal Neoplasms","Colorectal Cancer Metastatic","Adenocarcinoma Of The Colon","Advanced Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2057654"],"location":["Romania","Czechia","United States","Portugal","Russia","Spain","Greece","New Zealand","Canada","South Korea","Belgium","Brazil","Poland","Australia"],"study_start_month":["10"],"keyword":["Folic Acid","Oxaliplatin","ABT-869","Levoleucovorin","Leucovorin","Fluorouracil","Bevacizumab"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer","description":"To determine the effect of ABT-869 plus mFOLFOX6 compared to bevacizumab plus mFOLFOX6 on disease progression in advanced colorectal cancer.","dates":{"creation":"2008-10-15"},"accession":"2057654","cross_references":{"ClinicalTrials___gov":["NCT00707889"],"EU Clinical Trials Register":["2007-007081-38"]}}